 Home > Active Ingredient News > Antitumor Therapy > AACR 2020: NK Cell Therapy ACE1702 shows positive preclinical data

AACR 2020: NK Cell Therapy ACE1702 shows positive preclinical data

 Last Update: 2020-07-13
 Source: Internet
 Author: User

Tags

live cancer cells

abdominal wall cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Acepodia is a biotechnology company dedicated to the development of cancerimmunotherapy, ace1702 is a natural killer cell (NK cell) therapy, is being developed to treat HER2-positive solid tumorsPreclinical data for ACE1702 are presented in 2020 at the American Association for Cancer Research (AACR)ACE1702 is an Acepodia cell therapy candidate, and the U.SFood and DrugadministrationAdministration (
FDA) recently approved ace1702's research new drug application (IND) and will be evaluated in Phase I clinical trialsDr Sonny Hsiao, CEO of Acepodia, said: "Solid tumors pose a serious challenge to current cell therapyACE1702 is our first clinical candidate using antibody-cell binding technology that combines the target specificity of antibodies with the anti-tumor capabilities of natural killer cells."in preclinical models, ACE1702 exhibited cytotoxicity to a variety of her2-positive cancer cell lines;

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.